Quick Answer
Translational Development Acquisition Corp. reported Net Income of $6.36 million for fiscal year 2025.
Translational Development Acquisition Corp. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $6.36M | +9059.7% |
| 2024 | -$71.0K | +85.4% |
| 2023 | -$485.6K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.66M | +2808.9% | +2.3% |
| June 30, 2025 | $1.62M | +96440.8% | +9.5% |
| March 31, 2025 | $1.48M | — | +2520.0% |
| September 30, 2024 | -$61.3K | — | -3537.0% |
| June 30, 2024 | -$1.7K | — | — |
| March 31, 2024 | $0.00 | — | — |
- Translational Development Acquisition Corp. showed an increase of +9059.7% in Net Income compared to the prior fiscal year.
- Over the 2023–2025 period, Translational Development Acquisition Corp.’s net income has grown by 1410.4% (from -$485.6 thousand to $6.36 million).
- The most recent figure is from Translational Development Acquisition Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: